Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry

Hughes, 1983, Thrombosis, abortion, cerebral disease, and the lupus anticoagulant, Br Med J, 287, 1088, 10.1136/bmj.287.6399.1088 Cervera, 2002, Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients, Arthritis Rheum, 46, 1019, 10.1002/art.10187 Asherson, 1992, The catastrophic antiphospholipid syndrome, J Rheumatol, 19, 508 Cervera, 2014, 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome, Autoimmun Rev, 13, 699, 10.1016/j.autrev.2014.03.002 Cervera, 2012, CAPS Registry, Lupus, 21, 755, 10.1177/0961203312436866 Asherson, 2003, Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines, Lupus, 12, 530, 10.1191/0961203303lu394oa Cervera, 2009, Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the “CAPS Registry”, J Autoimmun, 32, 240, 10.1016/j.jaut.2009.02.008 Asherson, 1998, Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients, Medicine (Baltimore), 77, 195, 10.1097/00005792-199805000-00005 Asherson, 2001, Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients, Medicine (Baltimore), 80, 355, 10.1097/00005792-200111000-00002 Garcia-Carrasco, 2015, The role of infectious diseases in the catastrophic antiphospholipid syndrome, Autoimmun Rev, 14, 1066, 10.1016/j.autrev.2015.07.009 Ortega-Hernandez, 2009, The physiopathology of the catastrophic antiphospholipid (Asherson's) syndrome: compelling evidence, J Autoimmun, 32, 1, 10.1016/j.jaut.2008.10.003 Espinosa, 2007, Catastrophic antiphospholipid syndrome and sepsis. A common link?, J Rheumatol, 34, 923 Asherson, 2000, The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome-molecular mimicry?, J Rheumatol, 27, 12 Edgren, 2012, Enigmatic sex disparities in cancer incidence, Eur J Epidemiol, 27, 187, 10.1007/s10654-011-9647-5 Ramos-Casals, 2003, Autoimmunity and geriatrics: clinical significance of autoimmune manifestations in the elderly, Lupus, 12, 341, 10.1191/0961203303lu383ed Montoya-Ortiz, 2013, Immunosenescence, aging, and systemic lupus erythematous, Autoimmune Dis, 2013 Cervera, 1993, Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus, Medicine (Baltimore), 72, 113, 10.1097/00005792-199303000-00005 Cervera, 2003, Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients, Medicine (Baltimore), 82, 299, 10.1097/01.md.0000091181.93122.55 Ershler, 2003, Cancer: a disease of the elderly, J Support Oncol, 1, 5 Denas, 2015, Antiphospholipid syndrome and the heart: a case series and literature review, Autoimmun Rev, 14, 214, 10.1016/j.autrev.2014.11.003 Bayraktar, 2007, The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus, J Rheumatol, 34, 346 Abreu, 2015, The relevance of “non-criteria” clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features, Autoimmun Rev, 14, 401, 10.1016/j.autrev.2015.01.002